Genomic and biochemical characterization of Acinetobacter podophage Petty reveals a novel lysis mechanism and tail-associated depolymerase activity

A. C. Hernandez-Morales, L. L. Lessor, T. L. Wood, D. Migl, E. M. Mijalis, J. Cahill, W. K. Russell, R. F. Young, J. J. Gill

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The increased prevalence of drug-resistant, nosocomial Acinetobacter infections, particularly from pathogenic members of the Acinetobacter calcoaceticusbaumannii complex, necessitates the exploration of novel treatments such as phage therapy. In the present study, we characterized phage Petty, a novel podophage that infects multidrug-resistant Acinetobacter nosocomialis and Acinetobacter baumannii. Genome analysis reveals that phage Petty is a 40,431-bp ΦKMV-like phage, with a coding density of 92.2% and a G+C content of 42.3%. Interestingly, the lysis cassette encodes a class I holin and a single-subunit endolysin, but it lacks canonical spanins to disrupt the outer membrane. Analysis of other ΦKMV-like genomes revealed that spaninless lysis cassettes are a feature of phages infecting Acinetobacter within this subfamily of bacteriophages. The observed halo surrounding Petty's large clear plaques indicated the presence of a phage-encoded depolymerase capable of degrading capsular exopolysaccharides (EPS). The product of gene 39, a putative tail fiber, was hypothesized to possess depolymerase activity based on weak homology to previously reported phage tail fibers. The 101.4-kDa protein gene product 39 (gp39) was cloned and expressed, and its activity against Acinetobacter EPS in solution was determined. The enzyme degraded purified EPS from its host strain A. nosocomialis AU0783, reducing its viscosity, and generated reducing ends in solution, indicative of hydrolase activity. Given that the accessibility to cells within a biofilm is enhanced by degradation of EPS, phages with depolymerases may have enhanced diagnostic and therapeutic potential against drug-resistant Acinetobacter strains.

Original languageEnglish (US)
Article numbere01064-17
JournalJournal of virology
Volume92
Issue number6
DOIs
StatePublished - Mar 1 2018
Externally publishedYes

Fingerprint

Acinetobacter
bacteriophages
Bacteriophages
tail
genomics
exopolysaccharides
endolysin
Acinetobacter Infections
Genome
Acinetobacter baumannii
host strains
drugs
genome
Base Composition
Hydrolases
Biofilms
Cross Infection
hydrolases
Viscosity
Pharmaceutical Preparations

Keywords

  • Acinetobacter baumannii
  • Acinetobacter nosocomialis
  • Depolymerase
  • Genome analysis
  • Lysis
  • Phage therapy
  • Spanins

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Insect Science
  • Virology

Cite this

Hernandez-Morales, A. C., Lessor, L. L., Wood, T. L., Migl, D., Mijalis, E. M., Cahill, J., ... Gill, J. J. (2018). Genomic and biochemical characterization of Acinetobacter podophage Petty reveals a novel lysis mechanism and tail-associated depolymerase activity. Journal of virology, 92(6), [e01064-17]. https://doi.org/10.1128/JVI.01064-17

Genomic and biochemical characterization of Acinetobacter podophage Petty reveals a novel lysis mechanism and tail-associated depolymerase activity. / Hernandez-Morales, A. C.; Lessor, L. L.; Wood, T. L.; Migl, D.; Mijalis, E. M.; Cahill, J.; Russell, W. K.; Young, R. F.; Gill, J. J.

In: Journal of virology, Vol. 92, No. 6, e01064-17, 01.03.2018.

Research output: Contribution to journalArticle

Hernandez-Morales, A. C. ; Lessor, L. L. ; Wood, T. L. ; Migl, D. ; Mijalis, E. M. ; Cahill, J. ; Russell, W. K. ; Young, R. F. ; Gill, J. J. / Genomic and biochemical characterization of Acinetobacter podophage Petty reveals a novel lysis mechanism and tail-associated depolymerase activity. In: Journal of virology. 2018 ; Vol. 92, No. 6.
@article{66c840ac3a0948b0b4166cd70df0fe6f,
title = "Genomic and biochemical characterization of Acinetobacter podophage Petty reveals a novel lysis mechanism and tail-associated depolymerase activity",
abstract = "The increased prevalence of drug-resistant, nosocomial Acinetobacter infections, particularly from pathogenic members of the Acinetobacter calcoaceticusbaumannii complex, necessitates the exploration of novel treatments such as phage therapy. In the present study, we characterized phage Petty, a novel podophage that infects multidrug-resistant Acinetobacter nosocomialis and Acinetobacter baumannii. Genome analysis reveals that phage Petty is a 40,431-bp ΦKMV-like phage, with a coding density of 92.2{\%} and a G+C content of 42.3{\%}. Interestingly, the lysis cassette encodes a class I holin and a single-subunit endolysin, but it lacks canonical spanins to disrupt the outer membrane. Analysis of other ΦKMV-like genomes revealed that spaninless lysis cassettes are a feature of phages infecting Acinetobacter within this subfamily of bacteriophages. The observed halo surrounding Petty's large clear plaques indicated the presence of a phage-encoded depolymerase capable of degrading capsular exopolysaccharides (EPS). The product of gene 39, a putative tail fiber, was hypothesized to possess depolymerase activity based on weak homology to previously reported phage tail fibers. The 101.4-kDa protein gene product 39 (gp39) was cloned and expressed, and its activity against Acinetobacter EPS in solution was determined. The enzyme degraded purified EPS from its host strain A. nosocomialis AU0783, reducing its viscosity, and generated reducing ends in solution, indicative of hydrolase activity. Given that the accessibility to cells within a biofilm is enhanced by degradation of EPS, phages with depolymerases may have enhanced diagnostic and therapeutic potential against drug-resistant Acinetobacter strains.",
keywords = "Acinetobacter baumannii, Acinetobacter nosocomialis, Depolymerase, Genome analysis, Lysis, Phage therapy, Spanins",
author = "Hernandez-Morales, {A. C.} and Lessor, {L. L.} and Wood, {T. L.} and D. Migl and Mijalis, {E. M.} and J. Cahill and Russell, {W. K.} and Young, {R. F.} and Gill, {J. J.}",
year = "2018",
month = "3",
day = "1",
doi = "10.1128/JVI.01064-17",
language = "English (US)",
volume = "92",
journal = "Journal of Virology",
issn = "0022-538X",
publisher = "American Society for Microbiology",
number = "6",

}

TY - JOUR

T1 - Genomic and biochemical characterization of Acinetobacter podophage Petty reveals a novel lysis mechanism and tail-associated depolymerase activity

AU - Hernandez-Morales, A. C.

AU - Lessor, L. L.

AU - Wood, T. L.

AU - Migl, D.

AU - Mijalis, E. M.

AU - Cahill, J.

AU - Russell, W. K.

AU - Young, R. F.

AU - Gill, J. J.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - The increased prevalence of drug-resistant, nosocomial Acinetobacter infections, particularly from pathogenic members of the Acinetobacter calcoaceticusbaumannii complex, necessitates the exploration of novel treatments such as phage therapy. In the present study, we characterized phage Petty, a novel podophage that infects multidrug-resistant Acinetobacter nosocomialis and Acinetobacter baumannii. Genome analysis reveals that phage Petty is a 40,431-bp ΦKMV-like phage, with a coding density of 92.2% and a G+C content of 42.3%. Interestingly, the lysis cassette encodes a class I holin and a single-subunit endolysin, but it lacks canonical spanins to disrupt the outer membrane. Analysis of other ΦKMV-like genomes revealed that spaninless lysis cassettes are a feature of phages infecting Acinetobacter within this subfamily of bacteriophages. The observed halo surrounding Petty's large clear plaques indicated the presence of a phage-encoded depolymerase capable of degrading capsular exopolysaccharides (EPS). The product of gene 39, a putative tail fiber, was hypothesized to possess depolymerase activity based on weak homology to previously reported phage tail fibers. The 101.4-kDa protein gene product 39 (gp39) was cloned and expressed, and its activity against Acinetobacter EPS in solution was determined. The enzyme degraded purified EPS from its host strain A. nosocomialis AU0783, reducing its viscosity, and generated reducing ends in solution, indicative of hydrolase activity. Given that the accessibility to cells within a biofilm is enhanced by degradation of EPS, phages with depolymerases may have enhanced diagnostic and therapeutic potential against drug-resistant Acinetobacter strains.

AB - The increased prevalence of drug-resistant, nosocomial Acinetobacter infections, particularly from pathogenic members of the Acinetobacter calcoaceticusbaumannii complex, necessitates the exploration of novel treatments such as phage therapy. In the present study, we characterized phage Petty, a novel podophage that infects multidrug-resistant Acinetobacter nosocomialis and Acinetobacter baumannii. Genome analysis reveals that phage Petty is a 40,431-bp ΦKMV-like phage, with a coding density of 92.2% and a G+C content of 42.3%. Interestingly, the lysis cassette encodes a class I holin and a single-subunit endolysin, but it lacks canonical spanins to disrupt the outer membrane. Analysis of other ΦKMV-like genomes revealed that spaninless lysis cassettes are a feature of phages infecting Acinetobacter within this subfamily of bacteriophages. The observed halo surrounding Petty's large clear plaques indicated the presence of a phage-encoded depolymerase capable of degrading capsular exopolysaccharides (EPS). The product of gene 39, a putative tail fiber, was hypothesized to possess depolymerase activity based on weak homology to previously reported phage tail fibers. The 101.4-kDa protein gene product 39 (gp39) was cloned and expressed, and its activity against Acinetobacter EPS in solution was determined. The enzyme degraded purified EPS from its host strain A. nosocomialis AU0783, reducing its viscosity, and generated reducing ends in solution, indicative of hydrolase activity. Given that the accessibility to cells within a biofilm is enhanced by degradation of EPS, phages with depolymerases may have enhanced diagnostic and therapeutic potential against drug-resistant Acinetobacter strains.

KW - Acinetobacter baumannii

KW - Acinetobacter nosocomialis

KW - Depolymerase

KW - Genome analysis

KW - Lysis

KW - Phage therapy

KW - Spanins

UR - http://www.scopus.com/inward/record.url?scp=85042500498&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042500498&partnerID=8YFLogxK

U2 - 10.1128/JVI.01064-17

DO - 10.1128/JVI.01064-17

M3 - Article

C2 - 29298884

AN - SCOPUS:85042500498

VL - 92

JO - Journal of Virology

JF - Journal of Virology

SN - 0022-538X

IS - 6

M1 - e01064-17

ER -